ZFAT
History
Relevance tier by entity
| Entity | Tier | Description |
|---|---|---|
 |
2-F | failed QC |
Mutation incidence in large patient cohorts (GAMBL reanalysis)
| Entity | source | frequency (%) |
|---|---|---|
| DLBCL | GAMBL genomes | 1.34 |
| DLBCL | Schmitz cohort | 2.77 |
| DLBCL | Reddy cohort | 2.70 |
| DLBCL | Chapuy cohort | 2.56 |
Mutation pattern and selective pressure estimates
| Entity | aSHM | Significant selection | dN/dS (missense) | dN/dS (nonsense) |
|---|---|---|---|---|
| BL | No | No | 0.000 | 0 |
| DLBCL | No | No | 1.873 | 0 |
| FL | No | No | 0.000 | 0 |
View coding variants in ProteinPaint hg19 or hg38
View all variants in GenomePaint hg19 or hg38
ZFAT Expression
All Mutations
Reddy_2235T Reddy_2475T Reddy_2616T Reddy_2662T Reddy_2720T Reddy_3388T Reddy_3399T Reddy_3429T Reddy_3472T Reddy_3521T Reddy_3642T Reddy_3687T Reddy_3745T Reddy_3834T Reddy_3845T Reddy_3913T Reddy_3923T Reddy_3943T Reddy_3950T Reddy_3983T Reddy_3991T Reddy_4000T
References
Citing
If you use the information or data from this site, please cite
Krysta Coyle, Kostiantyn Dreval, Daniel Hodson and Ryan D. Morin. Audit of B-cell cancer genes. Blood Adv (2025) 9 (8): 2019–2031.
Disclaimer
The content in these pages has been populated, in part, by an automated process. Although we have scrutinized every page to ensure accuracy, errors will inevitably exist. If you find an error please report it as an issue and we will address it.
License
This work is licensed under a Creative Commons Attribution 4.0 International License.
You are free to:
Share — copy and redistribute the material in any medium or format for any purpose, even commercially.
Adapt — remix, transform, and build upon the material for any purpose, even commercially. The licensor cannot revoke these freedoms as long as you follow the license terms.
